ST-GLIPTIN DAPA : Uses, Side Effects, Interactions, Dosage and Call to Action.

ST-GLIPTIN DAPA

Sitagliptin Phosphate and Dapagliflozin

ST-GLIPTIN DAPA combines Sitagliptin Phosphate and Dapagliflozin, two powerful medications used in the management of type 2 diabetes. This dual-action therapy enhances glycemic control by acting through different but complementary mechanisms, improving insulin release in response to meals and reducing sugar reabsorption in the kidneys, respectively. This guide delves into the detailed aspects of uses, dosage instructions, pricing, potential side effects, and composition of ST-GLIPTIN DAPA.

Uses

ST-GLIPTIN DAPA is utilized for:

• Improving Blood Sugar Control in Type 2 Diabetes: It helps manage blood sugar levels, which can prevent the long-term complications of diabetes, such as nerve and kidney damage, heart disease, and eye problems.
• Enhancing Overall Diabetes Management: The combination of these two drugs offers a comprehensive approach that may reduce the need for future insulin use.

Dosage and Administration

• Standard Dosage: The usual dosage is determined by the specific needs of the patient and the discretion of the healthcare provider. Typically, patients start with a standard dose taken once daily.
• Method of Administration: ST-GLIPTIN DAPA should be taken orally, with or without food, preferably at the same time each day to maintain even medication levels in the bloodstream.
• Dosage Adjustments: Dosage may be adjusted based on the effectiveness and tolerability as assessed during regular follow-up visits with the healthcare provider.

Price

The price of ST-GLIPTIN DAPA can vary widely depending on several factors, including the geographic location, pharmacy chains, and whether the patient has health insurance. It is generally priced on the higher end of the spectrum due to its advanced formulation, but generic options may offer cost-saving opportunities.

Side Effects

While ST-GLIPTIN DAPA is effective for managing diabetes, it may cause side effects in some individuals:

• Common Side Effects: Nasopharyngitis, urinary tract infections, and headaches. Sitagliptin may cause joint pain and nausea, while Dapagliflozin may lead to genital infections and increased urination.
• Serious Side Effects: Rare but serious side effects include the risk of pancreatic inflammation (pancreatitis), heart failure (particularly with Dapagliflozin in patients with existing heart diseases), and diabetic ketoacidosis, a serious condition caused by insufficient insulin.
• Precautions: Patients with a history of pancreatitis, severe kidney impairment, or severe heart conditions should use this medication cautiously and under strict medical supervision.

Composition

Each dose of ST-GLIPTIN DAPA contains:

• Active Ingredients: Sitagliptin Phosphate at a clinically appropriate dose and Dapagliflozin.
• Inactive Ingredients: May include fillers and binders like cellulose, starch, and magnesium stearate, which are standard in tablet formulations to ensure proper dissolution and absorption.

Conclusion

ST-GLIPTIN DAPA represents a significant advancement in the treatment of type 2 diabetes, offering patients a powerful combination therapy capable of improving glycemic control with a single tablet. By addressing different aspects of diabetes management, this medication can help reduce the risk of diabetes-related complications significantly. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. Gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW